Literature DB >> 18649734

Prostate specific antigen gene expression in androgen insensitive prostate carcinoma subculture cell line.

Ke-Hung Tsui1, Tsui-Hsia Feng, Li-Chuan Chung, Chun-Hsiang Chao, Phei-Lang Chang, Horng-Heng Juang.   

Abstract

A novel prostate cancer cell line (PC-J) was isolated from an androgen independent non-prostate specific antigen (non-PSA) producing carcinoma cell line. The homologous correlation between PC-J and PC-3 was determined by short tandem repeat analysis. The PSA promoter activity was detected by transient expression assay in the PC-J and LNCaP cells but not in androgen insensitive PC-3 cells. When the PC-J cells were cotransfected with androgen receptor, androgen receptor coactivators and PSA reporter vector cells, the reporter assays indicated that nuclear receptor coactivator 4 (NCOA4) but not androgen receptor activator 24 (ARA24) increased the sensitivity and maximum stimulation of dihydrotestosterone (DHT)-inducing PSA promoter activity. The RT-PCR assays revealed that the expression of several tumor markers, including interleukin-6, prostate stem cell antigen (PSCA), prostate epithelium-specific Ets transcription factor (PDEF) and matriptase, was lower in the PC-J cells than in the PC-3 cells. This cell model elucidated the regulation of PSA expression and enabled comparison of the gene profile at different stages of metastasis in prostatic carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18649734

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Serum alkaline phosphatase differentiates prostate-specific antigen flare from early disease progression after docetaxel chemotherapy in castration-resistant prostate cancer with bone metastasis.

Authors:  Kyung Seok Han; Sung Joon Hong
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-24       Impact factor: 4.553

2.  The inhibitory effects of capillarisin on cell proliferation and invasion of prostate carcinoma cells.

Authors:  Ke-Hung Tsui; Ying-Ling Chang; Pei-Shan Yang; Chen-Pang Hou; Yu-Hsiang Lin; Bing-Wei Lin; Tsui-Hsia Feng; Horng-Heng Juang
Journal:  Cell Prolif       Date:  2017-12-21       Impact factor: 6.831

3.  Prostate-specific antigen flare induced by 223RaCl2 in patients with metastatic castration-resistant prostate cancer.

Authors:  Angelo Castello; H A Macapinlac; E Lopci; E B Santos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-21       Impact factor: 9.236

4.  Exponential rise in prostate-specific antigen (PSA) during anti-androgen withdrawal predicts PSA flare after docetaxel chemotherapy in patients with castration-resistant prostate cancer.

Authors:  Kyung Seok Han; Sung Joon Hong
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

5.  Topoisomerase inhibitors modulate gene expression of B-cell translocation gene 2 and prostate specific antigen in prostate carcinoma cells.

Authors:  Kun-Chun Chiang; Ke-Hung Tsui; Li-Chuan Chung; Chun-Nan Yeh; Phei-Lang Chang; Wen-Tsung Chen; Horng-Heng Juang
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

6.  Celastrol blocks interleukin-6 gene expression via downregulation of NF-κB in prostate carcinoma cells.

Authors:  Kun-Chun Chiang; Ke-Hung Tsui; Li-Chuan Chung; Chun-Nan Yeh; Wen-Tsung Chen; Phei-Lang Chang; Horng-Heng Juang
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.